WAM
MDGL icon

Wolverine Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Wolverine Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,300
Closed -$5.27M – 1531
2019
Q2 		$5.27M Buy
+50,300
New +$5.39M 0.07% 226

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wolverine Asset Management's MDGL Position: Q2 2021 in Review

Wolverine Asset Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2021, closing a stake of 126 shares — an estimated $14K sold.

Wolverine Asset Management first reported a position in MDGL in Q2 2013 and held it in 5 quarters. The position peaked at $239K in Q4 2013. 151 funds tracked by Wall St. Rank hold MDGL as of Q2 2021.

  • Wolverine Asset Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 126 Madrigal Pharmaceuticals shares in Q2 2021, an estimated $14K.
  • Wolverine Asset Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Wolverine Asset Management's Madrigal Pharmaceuticals position peaked at $239K in Q4 2013.
  • 151 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.